Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in Thailand

被引:30
作者
Sharma, M. [1 ]
Ortendahl, J. [1 ]
van der Ham, E. [2 ]
Sy, S. [1 ]
Kim, J. J. [1 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Hlth Decis Sci, Boston, MA 02115 USA
[2] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands
基金
比尔及梅琳达.盖茨基金会;
关键词
Cervical cancer; cost-effectiveness; human papillomavirus; screening; Thailand; vaccination; DEVELOPING-COUNTRIES; HPV-18; VACCINATION; IMPACT; PREVENTION; HEALTH; INDIA; ACCEPTABILITY; ATTITUDES; PROGRAMS; VIETNAM;
D O I
10.1111/j.1471-0528.2011.02974.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Please cite this paper as: Sharma M, Ortendahl J, van der Ham E, Sy S, Kim J. Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in Thailand. BJOG 2012;119:166176.
引用
收藏
页码:166 / 176
页数:11
相关论文
共 50 条
[21]   Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary [J].
Voko, Zoltan ;
Nagyjanosi, Laszlo ;
Kalo, Zoltan .
BMC PUBLIC HEALTH, 2012, 12
[22]   Cost-effectiveness of a cervical screening program with human papillomavirus vaccine [J].
Sopina, Elizaveta ;
Ashton, Toni .
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2011, 27 (04) :290-297
[23]   Cost-effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in Québec, Canada [J].
Arthi Vijayaraghavan ;
Molly B. Efrusy ;
Marie-Hélène Mayrand ;
Christopher C. Santas ;
Patricia Goggin .
Canadian Journal of Public Health, 2010, 101 :220-225
[24]   Cost-effectiveness analysis of 9-valent human papillomavirus vaccine combined with screening for cervical cancer in Japan [J].
Takamoto, Naohiro ;
Aso, Shotaro ;
Ishida, Risa ;
Konishi, Takaaki ;
Fushimi, Kiyohide ;
Yasunaga, Hideo .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2025, 169 (02) :788-801
[25]   Cost-effectiveness of human papillomavirus vaccination and screening in Spain [J].
Diaz, Mireia ;
de Sanjose, Silvia ;
Ortendahl, Jesse ;
O'Shea, Meredith ;
Goldie, Sue J. ;
Bosch, F. Xavier ;
Kim, Jane J. .
EUROPEAN JOURNAL OF CANCER, 2010, 46 (16) :2973-2985
[26]   A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines [J].
Guerrero, Anna Melissa ;
Genuino, Anne Julienne ;
Santillan, Melanie ;
Praditsitthikorn, Naiyana ;
Chantarastapornchit, Varit ;
Teerawattananon, Yot ;
Alejandria, Marissa ;
Toral, Jean Anne .
BMC PUBLIC HEALTH, 2015, 15
[27]   A generally applicable cost-effectiveness model for the evaluation of vaccines against cervical cancer [J].
Demarteau, Nadia ;
Detournay, Bruno ;
Tehard, Bertrand ;
El Hasnaoui, Abdelkader ;
Standaert, Baudouin .
INTERNATIONAL JOURNAL OF PUBLIC HEALTH, 2011, 56 (02) :153-162
[28]   Cost-effectiveness analysis of cervical cancer prevention based on a rapid human papillomavirus screening test in a high-risk region of China [J].
Levin, Carol E. ;
Sellors, John ;
Shi, Ju-Fang ;
Ma, Li ;
Qiao, You-lin ;
Ortendahl, Jesse ;
O'Shea, Meredith K. H. ;
Goldie, Sue J. .
INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (06) :1404-1411
[29]   Human Papillomavirus Testing in Cervical Cancer Screening [J].
Castle, Philip E. ;
Cremer, Miriam .
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2013, 40 (02) :377-+
[30]   Modeling the epidemiological impact and cost-effectiveness of a combined schoolgirl HPV vaccination and cervical cancer screening program among Chinese women [J].
Ma, Xiaomeng ;
Harripersaud, Katherine ;
Smith, Kumi ;
Fairley, Christopher K. ;
Zou, Huachun ;
Zou, Zhuoru ;
Wang, Yueyun ;
Zhuang, Guihua ;
Zhang, Lei .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (04) :1073-1082